Wesley Campbell, MD, of U.S. Navy Medicine, presents "An AIDS-Defining Illness Presenting during Acute Retroviral Syndrome: A Case Discussion and Review of the Literature" for AIDS Clinical Rounds at UC San Diego
Wesley Campbell, MD, of U.S. Navy Medicine, presents "An AIDS-Defining Illness Presenting during Acute Retroviral Syndrome: A Case Discussion and Review of the Literature" for AIDS Clinical Rounds at UC San Diego
Edward Cachay, MD, MAS
Professor of Medicine
Division of Infectious Diseases & Global Public Health
Department of Medicine
University of California, San Diego
Department of Global Health Lecture Series
Judd Walson
December 2, 2008
'Delaying HIV-1 Disease Progression in Pre-HAART Positives; The Role of Treating Endemic
In this presentation we provide the evidence that dengue fever is transmissible through blood transfusions. A discussion can be found at The Brazilian Blood Journal.
Identification of AIDS? And what is HIV infection and mode of transmission?Hassan Shaker
This presentation includes the following:
1) What are viruses and its classification
2) Over view of HIV infection
3) Development of HIV infection into AIDS.
4) HIV infection's clinical features and its complications.
5) Life cycle of HIV infection.
6) Mode of transmission of HIV infection.
7) How to diagnose HIV infection.
8) How to manage HIV infection.
9) Explain different preventive measures to prevent sexually transmitted viral infection
Presentation by Michael Healy, Student Intern from Sydney University at the Milton Pink Eye Workshop held on the 18th June 2009. This Presentation covers:
- What is Bovine Viral Diarrhoea (BVDV) or Pertivirus
- Case Study on a South Coast Diary Herd
- Control Methods
Edward Cachay, MD, MAS
Professor of Medicine
Division of Infectious Diseases & Global Public Health
Department of Medicine
University of California, San Diego
Department of Global Health Lecture Series
Judd Walson
December 2, 2008
'Delaying HIV-1 Disease Progression in Pre-HAART Positives; The Role of Treating Endemic
In this presentation we provide the evidence that dengue fever is transmissible through blood transfusions. A discussion can be found at The Brazilian Blood Journal.
Identification of AIDS? And what is HIV infection and mode of transmission?Hassan Shaker
This presentation includes the following:
1) What are viruses and its classification
2) Over view of HIV infection
3) Development of HIV infection into AIDS.
4) HIV infection's clinical features and its complications.
5) Life cycle of HIV infection.
6) Mode of transmission of HIV infection.
7) How to diagnose HIV infection.
8) How to manage HIV infection.
9) Explain different preventive measures to prevent sexually transmitted viral infection
Presentation by Michael Healy, Student Intern from Sydney University at the Milton Pink Eye Workshop held on the 18th June 2009. This Presentation covers:
- What is Bovine Viral Diarrhoea (BVDV) or Pertivirus
- Case Study on a South Coast Diary Herd
- Control Methods
Zoonoses (Greek “zoon” = animal) are the diseases or infections that are naturally transmissible from vertebrate animals to humans. This group of infections constitutes significant burdens on global public health. The World Health Organisation (WHO) estimates that 25% of the total 57 million annual deaths that occur globally are caused by microbes with a major proportion occurring in the developing world (Chugh, 2008). Of total identified 1,415 species of infectious organisms known to be pathogenic to humans (including 217 viruses and prions, 538 bacteria and rickettsia, 307 fungi, 66 protozoa and 287 helminths), zoonotic agents constitute 868 (61%), with humans serving as the primary reservoir for only 3% of them. Of the 175 diseases considered to be emerging, 132 (75%) are zoonotic in origin (Taylor et al., 2001). In low income countries, established and emerging zoonoses make up 26 % of the DALYs (Disability-adjusted life year) lost to infectious disease and 10 % of the total DALYs lost. In contrast, in high income countries it represent < 1 % of DALYs lost to infectious disease and only 0.02 % of the total disease burden (Grace et al., 2012).
Vectors are living organisms that can transmit infectious diseases between humans or from animals to humans. Vector-borne diseases are infections transmitted by the bite of infected arthropod species, such as mosquitoes, ticks, triatomine bugs, flies, fleas, sandflies, and blackflies (Confalonieri et al., 2007). Among these mosquitoes are the best known disease transmission vectors for many of the fatal and diseases of economic burden. Vector-borne diseases account for 17% of the estimated global burden of all infectious diseases (CDC, 2014). Every year > 1 billion people are infected and > 1 million people die from vector-borne diseases including malaria, dengue, schistosomiasis, leishmaniasis, yellow fever, lymphatic filariasis, Japanese encephalitis and onchocerciasis. One sixth of the illness and disability suffered worldwide is due to vector-borne diseases with more than half the world’s population currently estimated to be at risk of these diseases. Global trade, rapid international travel, unsustainable urbanization, environmental changes such as climate change and emerging insecticidal and drug resistances, are causing vectors and vector-borne diseases to spread beyond borders (WHO, 2014).
Hepatitis is an injury to liver characterised by presence of inflammatory cells in the liver tissue.
It can be self limiting,or It can progress to scarring of the liver.
Hepatitis viruses cause most cases of liver
damage worldwide
HIV (Human Immunodeficiency Virus) infects cells of the immune system and destroys or impairs their function.
Infection progressive deterioration of the immune system breaking down the body's ability to fight out infections & diseases by opportunistic bacteria, viruses and fungi.
AIDS (Acquired Immune Deficiency Syndrome) refers to the most advanced stages of HIV infection and a collection of signs and symptoms caused by more than 20 opportunistic infections or related cancers.
Basil Donovan from NCHECR addresses the global context; Australian trends in infectious syphilis; enhanced surveillance for syphilis; and the effects of syphilis on HIV infection, at AFAO's syphilis forum in May 2009.
Evolution and Revolution: Current Issues in HIV and HCV Co-infection
Chapter 1 – HIV-Hepatitis C Virus Co-infection: An evolving epidemic
Chapter 2 - Management of HIV infection in HIV/HCV co-infected patients
Chapter 3 - Management of HCV in co-infected patients
Chapter 4 - HCV Therapy: Direct acting antiviral agents in co-infected individuals
Chapter 5 - Drug interactions with directly acting antivirals for HCV: Overview & challenges in HIV/HCV Co-infection
Chapter 6 - Complicated cases
Chapter 7 - Future trials of Hepatitis C therapy in the HIV co-infected
Chapter 8 - HCV infection in marginalized populations
Chapter 9 - HIV/HCV Co-infection: Through the eyes of a co-infected hemophiliac
Epidermiologic pattern of viral hepatitis in afghanistanIslam Saeed
Epidemiology of Viral Hepatitis in Afghanistan. The presentation is prepared by Dr. Islam Saeed, Director for Surveillance/DEWS at Afghan National Public Health Institute (ANPHI), MoPH
Key Slides on ART for HIV : Evolving Concepts and Innovative Strategies.2020hivlifeinfo
Expert-authored slides on evolving ART concepts, including simplification to 2-drug therapy, ART safety during pregnancy, weight gain, and long-acting injectable ART.
File Size: 580 KB
Released: October 20, 2020
Manufacture of Immunoglobulin Therapies-Relationship to ThrombogenicityAlbert Farrugia
Presentation given to Workshop on Risk Mitigation Strategies to Address Procoagulant Activity in Immune Globulin Products
Universities at Shady Grove Conference Center
Rockville, Maryland,May 17-18, 2011
BRAZILIAN PROGRAM OF SELF-SUFFICIENCY IN BLOOD PRODUCTSAlbert Farrugia
Talk given by Dr G de Oliveira, ANVISA representative, at the 10th International Conference of Drug Regulatory Authorities (ICDRA) in HK, China, June 2002
Oration given on the occasion of the award of the Ruth Sanger Medal to Albert Farrugia by the Australia and New Zealand Society for Blood Transfusion, October 2009
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Emerging infectious threats to the blood supply
1. Emerging (and re-emerging) infectious risks to the global (and Australian) blood supply Albert Farrugia University of Canberra Faculty of Applied Science April 2007
2.
3.
4. Risk of HIV per Unit (%) Year of Transfusion First AIDS cases reported First TA-AIDS cases reported; High-risk donor deferral / self-exclusion initiated. HIV discovered; Progressive impact of high-risk donor education. Anti-HIV screening impmented Risk of HIV Transmission by Blood Transfusions Before the Implementation of HIV-1 Antibody Screening Busch et al. Transfusion 1991; 3: 4-11 2.0 1.5 1 0.5 0 1978 1979 1980 1981 1982 1985 1983 1984 1990
5.
6. Testing for Hepatitis C HCV RNA 0 10 20 30 40 50 60 70 80 90 100 - HCV MP-NAT - HCV ID-NAT Pre- MP NAT WP = 60 days ID-NAT WP = 3 days MP-NAT WP = 10 days Anti-HCV (3.0 EIA)
10. Adults and children estimated to be living with HIV/AIDS as of end 2002 Total: 42 million Western Europe 570 000 North Africa & Middle East 550 000 Sub-Saharan Africa 29.4 million Eastern Europe & Central Asia 1.2 million South & South-East Asia 6 million Australia & New Zealand 15 000 North America 980 000 Caribbean 440 000 Latin America 1.5 million East Asia & Pacific 1.2 million
11.
12. Risk/million repeat donations (with NAT) – High HDI * NAT not included (From: Glynn et al, Transfusion 2001) HIV HBV* HCV Australia 0.2 1.9 0.9 France 0.4 NA 0.1 Italy 1.1 2.1 6.6 Spain 1.0 13.5 6.0 US 0.5 4.9 0.5
13. HIV incidence, prevalence and risk PHT donations (RSA) Includes impact of HIV p24 antigen testing Prevalence Incidence Residual Risk High Prevalence 4850 512 14 (1:7100) Low Prevalence 99 12.9 0.7 (1:143000) Overall (NA) 62.8 3.4 (1:29400)
14. Range of coverage, prevalence and risk, Latin America, 2001-2 HIV HBV HCV T. cruzi Cov High Low 100% 86% 100% 93.4% 100% 49% 100% 25.1% Prev High Low 5.0/1k GUT 0.3 CHI 11.3 GUT 0.7 CHI 11.0 COL 1.3 CHI 99.1 BOL 1.5 ECU Risk High Low 11/10k 0 8.0 0 14.0 0 28.0 0
43. LAC SLE WN DEN2 WEE (VEE) CTF LAC SLE POW WN DEN2 EEE HJ EVE (VEE) EEE WEE VEE MAY WN DEN2 EEE WEE VEE MAY SLE WN YF DEN2 SIN CHIK WN YF DEN2 TAH SIN POW(TBE) WN (TAH,INK) CHIK SIN POW(TBE) JE WN SSH RR BF SIN MVE DEN2 Global Distribution of Major Human Flaviviruses
44.
45. West Nile Virus Transmission Cycle West Nile virus West Nile virus Mosquito vector Incidental infections Bird reservoir hosts Incidental infections
46. ~80 % Asymptomatic ~ 20% “ West Nile Fever” <1% CNS disease WNV Human Infection “Iceberg” in 2002 284 fatalities ~ 3300 severe disease ~ 400,000 asymptomatic ~100,000 mild illness
47. Human WNV infections WNV activity West Nile Virus Activity: 1999-2002 1999 2000 2001 2002
48.
49. WN virus infection in organ donor and four organ recipients, August 2002 WNV PCR-neg WNV IgM-neg Organ Donor Blood components 63 donors Organ Donor 36 hours WNV PCR-pos WNV culture-pos WNV IgM-neg F/U: 1 seroconverting donor; Retrieved, stored plasma – WNV PCR-positive Kidney recipient WNME (fatal) Kidney recipient WNME Liver recipient WNF Heart recipient WNME
50. Model for Relative Duration of Stages of WNV Infection 10 1 10 2 10 3 10 4 10 5 WNV RNA (gEq per mL) Days post infectious mosquito bite 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 RNA IgM IgG 6-7 days Stage-II IDNAT+ MPNAT- IgM- Stage-IV IDNAT+ MPNAT- IgM+ IgG+/- MP-NAT ID-NAT Stage-V IDNAT +/- MPNAT- IgM+ IgG+ Stage-I IDNAT+/-MPNAT- IgM- Stage-III MPNAT+ IgM-
55. Murray Valley encephalitis (MVE) and Kunjin virus disease are endemic in the tropical parts of the Northern Territory and Western Australia, but have been absent from Central Australia since 1974. In 2000, 5 laboratory-confirmed cases of encephalitis occurred over a short period in the normally dry inland region of Central Australia. The sudden occurrence of cases in March and April 2000 followed unusually high rainfall in the preceding months and evidence of flavivirus activity in the endemic areas in the Kimberley region of Western Australia . Further cases were reported in the following wet season, without preceding human cases in known endemic areas. These findings indicate the reintroduction of these viruses into Central Australia and establishment of local cycles of infection with an ongoing risk to the local population. This area may also act as a potential source for reintroduction of MVE into south-eastern Australia. Commun Dis Intell 2002;26:39-44.
56. World Distribution of Dengue 1999 Areas infested with Aedes aegypti Areas with Aedes aegypti and recent epidemic dengue
57.
58.
59. Temperature, Virus Positivity and Anti-Dengue IgM , by Fever Day Dengue IgM Mean Max. Temperature Virus Adapted from Figure 1 in Vaughn et al., J Infect Dis , 1997; 176:322-30. Fever Day Percent Virus Positive -4 -3 -2 -1 0 1 2 3 4 5 6 39.5 39.0 38.5 38.0 37.5 37.0 Temperature (degrees Celsius) Dengue IgM (EIA units) 0 20 40 60 80 100 300 150 0 75 225
75. Wei-Kung Wang, Chi-Tai Fang, Hui-Ling Chen et al. Detection of severe acute respiratory syndrome coronavirus RNA in plasma during the course of infection. J Clinical Microbiology. 2005;43(2):962-965.
76.
77.
78.
79. Total Exports of MBM 1988 - 1993 No data 0 - < 5 5 - < 10 10 - < 20 20 - < 100 100 - < 1.000 1.000 - < 10.000 > 10.000 Legend: (in tonnes)
80. Transmission of TSE by blood transfusion in hamsters Rohwer 2000 263 K scapie adapted hamster Exchange transfusion 2 ml blood (total blood volume = 7 ml) Normal hamster 2 ml blood removed 3 out of 100 transfusions resulted in transmission
85. Recipients surviving >5 yr post transfusion of blood components from vCJD/CJD Donors (using data from UK TMER and US ARC look-back studies [S Anderson, FDA; P Page, R Dodd ARC at FDA TSEAC 14 Oct 2004]) Fisher's Exact Test comparing rates of infection after transfusions from vCJD and CJD donors suggests a statistically significant difference between the two groups ( 1% likelihood that the difference occurred by chance). [Conclusion: Risk of TT CJD is much less than TT vCJD.] Infection No Infection vCJD 4 14 CJD 0 >116
86.
87.
88.
89.
90.
91.
92.
93.
94.
95.
96.
97.
98. Total Exports of MBM 1988 - 1993 No data 0 - < 5 5 - < 10 10 - < 20 20 - < 100 100 - < 1.000 1.000 - < 10.000 > 10.000 Legend: (in tonnes)